Cadence Raises $15M in a Healthy and Growing Neuromodulation Market

Cadence Raises $15M in a Healthy and Growing Neuromodulation Market

Source: 
Medical Devices and Diagnostics Industry
snippet: 

Cadence Neuroscience is moving to bring a neuromodulation therapy for patients with focal drug-resistant epilepsy to market. The Redmond, WA-based company has raised $15 million in a series A round to help with this goal.